MRD / Regn No. : 20250000640 Date : 04/06/2026
Patient Name : Mohammad Akther Hossen Age & Gender : 49 Yrs. / Male
Contact No. : 1711025505 UHID :
Ht / Wt / BMI : 164 / 68 / 25.28 BP S / BP D : 110 / 70
Allergies : NKA Referred By :
   
Problem List : TYPE 2 DM (22/Aug/2023) | DYSLIPIDEMIA (22/Aug/2025) | A1G2 DKD (22/Aug/2025) | NAFLD (26/Aug/2025) | VITAMIN D DEFICIENCY (09/Dec/2025) |
Subjective : TYPE 2 DM 2 YEARS,HYPERTRIGLYCERIDEMIA
Objective : NONE
Analysis : TYPE 2 DM,INCREASED FIB4 / NAFLD SCORE,A1G2 DKD,S3 F0 MASLD,VITAMIN D DEFICEINCY,GLUCOSES IMPROVED
Plan : CLINICAL FOLLOW UP,SEE ME IN 3 MONTHS WITH TESTING  
S# Generic (Trade) Name Route Dosage Usage Duration
1 TABLET SITAGLIPTIN 100 MG DAPAGLIFLOZIN 10 MG
SIAGLIDE D
Medicine For GLUCOSE CONTROL HEART KIDNEY PROTECTION
PO 1-0-0 BEFORE FOOD
TILL NEXT VIST
DAPAGLIFLOZIN MAY CAUSE GENITOURINARY INFECTIONS
2 ROSUVASTATIN 10 MG
ROSEDAY 10 MG
Medicine For CHOLESTEROL
PO 0-0-1 AT BEDTIME
TILL NEXT VISIT
MAY CAUSE FATIGUE AND MUSCLE PAIN
3 TELMISARTAN 40 MG
TELMA 40 MG
0-0-1 AT BEDTIME
TILL NEXT VISIT
4 PIOZ 15 MG
PIOGLITAZONE 15 MG
1-0-0 BEFORE FOOD
TILL NEXT VISIT
MAY CAUSE SWELLING OF THE FEET
5 CAPSULE CHOLECALCIFEROL 2000 IU
D RISE
Medicine For VITAMIN D
PO 0-0-1 AT BEDTIME
TILL NEXT VISIT
       
Refill : 0 / Substitution:    
Education :
Next Visit : 02/Sep/2026
Tests Suggested For Next Visit : FBS 2HPP HBA1C LIPID PROFILE CBC LFT
   
   

Dr. Krishna G Seshadri
Sr. Consultant Endocrinology Diabetes and Metabolism
Tamil Nadu / 48748 HPRID: 71-0638-2075-7542

This is a Computer generated Prescription

Powered By: